Core Viewpoint - The document outlines the investor relations management system of Zhuhai Hengji Daxin International Chemical Storage Co., Ltd, emphasizing the importance of fair, transparent, and compliant communication with investors to enhance corporate governance and overall value [1][2]. Chapter Summaries Chapter 1: General Principles - The company establishes this system to regulate its operations, protect investor rights, and improve quality based on relevant laws and regulations [1]. Chapter 2: Requirements and Basic Principles of Investor Relations Management - Investor relations management should adhere to principles of compliance, equality, proactivity, and honesty, ensuring fair treatment of all investors, especially minority shareholders [2][3]. Chapter 3: Responsibilities and Setup of Investor Relations Management Department - The board secretary is designated as the head of investor relations management, coordinating activities and ensuring compliance with disclosure regulations [3][4]. Chapter 4: Investor Relations Management Activities - The company is responsible for handling investor complaints and must ensure equal treatment of all investors during communication activities [5][6]. Chapter 5: Information Disclosure in Investor Relations Management Activities - The board secretary is responsible for managing investor relations and ensuring timely and accurate information disclosure [11][12]. Chapter 6: Supplementary Provisions - The system will be implemented upon approval by the board and will be subject to relevant laws and regulations [13][14].

Core Points - The document outlines the fundraising management measures for Zhuhai Hengji Daxin International Chemical Storage Co., Ltd, aiming to standardize the company's operations and protect the rights of investors [2][3] - It emphasizes the importance of proper use and management of raised funds, ensuring they align with the company's business objectives and legal regulations [6][7] Fundraising Overview - The term "raised funds" refers to capital obtained through stock issuance or other equity-like securities for specific purposes, excluding funds raised for equity incentive plans [2] - The company must establish a special account for raised funds, ensuring that these funds are not mixed with other financial resources [3] Fund Management and Usage - The board of directors is responsible for thoroughly evaluating the feasibility of investment projects funded by raised capital, ensuring they have good market prospects and profitability [3][6] - The company must disclose the actual usage of raised funds accurately and completely, and any significant deviations from the planned investment must be reported promptly [7][8] Fund Usage Restrictions - Raised funds should primarily be used for the company's main business activities and must not be used for high-risk investments or financial assistance to others [6][9] - Any changes in the use of raised funds require board approval and must be disclosed to shareholders [9][10] Monitoring and Reporting - The company is required to maintain detailed records of the usage of raised funds and undergo regular audits to ensure compliance with regulations [14][15] - Independent financial advisors or sponsors must conduct periodic checks on the management and usage of raised funds, reporting any irregularities to the relevant authorities [15][16]

Core Viewpoint - ST Shuntian (600287) has successfully removed the risk warning label and will resume trading under the name Jiangsu Shuntian starting July 16, 2024, following a self-assessment confirming compliance with the conditions for removal [1][2]. Group 1: Stock and Trading Information - The stock will be suspended for one day on July 15, 2024, and will resume trading with a change in the daily price fluctuation limit from 5% to 10% [1]. - The company was under risk warning due to an administrative penalty from the China Securities Regulatory Commission, which has now been resolved [1]. Group 2: Financial Adjustments and Liabilities - The company has corrected accounting errors and restated financial reports for the years 2009-2021 and the balance sheets for 2009-2022 and Q3 2023 [1]. - As of the announcement date, the company has recognized a provision for investor claims amounting to 3.77 million yuan, with an estimated liability of 331.20 million yuan recorded in the 2024 annual report [2]. Group 3: Business Segments and Revenue - The company's main business segments include commodity circulation, garment processing, and chemical warehousing, generating revenues of 3.069 billion yuan, 124 million yuan, and 20 million yuan respectively in 2024 [2]. - The gross profit margins for these segments are 14%, 3.56%, and 16.81% respectively, with domestic revenue at 1.203 billion yuan and overseas revenue at 2.009 billion yuan [2]. Group 4: Recent Performance - In Q1 2025, the company reported a revenue of 643 million yuan and a net profit attributable to shareholders of 8.27 million yuan [3].